Business · 11/06/2003Updated: 10/17/2026 · 1 min read
FDA Approves New Animal Drug for Osteoarthritis Pain in Dogs
Summary
The US Food and Drug Administration (FDA) has approved a new animal drug application for Schering-Plough Animal Health Corp.'s tepoxalin tablets, which are intended to treat pain and inflammation in dogs with osteoarthritis.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →